Displaying 1 - 1 of 1
| Active Ingredient | LAMOTRIGINE |
| Therapeutic Class | ANTICONVULSANTS MISCELLANEOUS |
| Indications |
Monotherapy or adjunctive treatment of partial seizures; primary and secondary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. To be used in women of child-bear More ... |
| Caution | Blurred vision; aggression; agitation; arthralgia; ataxia; back pain; diarrhoea; diplopia; dizziness; drowsiness; dry mouth; headache; insomnia; nausea; nystagmus; rash; tremor; vomiting. |
| Dose Range |
Adult and children 12 years and older: monotherapy: 25 mg once daily for 2 weeks followed by 50 mg once daily for 2 weeks; increased by a maximum of 50 to 100 mg every 1 to 2 weeks to usual maintenance doses of 100 to 200 mg daily, given as a sin |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |